Phaedra Chrousos serves as Executive at Vanda Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Phaedra Chrousos has executed 7 insider transactions totaling $40.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 22, 2024 involved receiving (via award) 21,887 shares valued at $0.
Phaedra Chrousos currently holds 64,125 shares of Vanda Pharmaceuticals Inc. (VNDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Phaedra Chrousos has been a net seller of VNDA stock. They have purchased $0 and sold $40.1K worth of shares.
Phaedra Chrousos's most recent insider trade was on May 22, 2024, when they sold 21,887 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 16, 2022 | VNDA | $0 | Award | 12,006 | $N/A | Discretionary |
| Jun 14, 2021 | VNDA | $40.1K | Sale | 2,075 | $19.34 | Discretionary |
| Jun 10, 2021 | VNDA | $0 | Award | 5,000 | $N/A | Discretionary |
| Jun 11, 2020 | VNDA | $0 | Award | 5,000 | $N/A | Discretionary |
| Jun 13, 2019 | VNDA | $0 | Award | 5,000 | $N/A | Discretionary |